← Leaderboards
William A. Beltran
University Of Pennsylvania
$14,525,140
Attributed
$24,512,984
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4M · FY2012–25$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$32,402,144 · 9
By mechanism
R24$12,606,880 · 3
R01$11,795,648 · 3
U24$7,261,894 · 1
P30$737,722 · 2
Top collaborators
- Gustavo David Aguirre8 shared
- John H Wolfe7 shared
- David M Gamm6 shared
- Leah Byrne4 shared
- Morgan Dileo4 shared
- Jose-Alain Sahel4 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Gustavo David Aguirre$22,398,317
- Eric A Pierce$25,662,965
- Andras Komaromy$6,828,118
- Geoffrey Karl Aguirre$8,964,160
- Artur V Cideciyan$5,096,772
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelClinical TrialsMutationRpe65 ProteinGenesAnimal ModelRetinaCanis FamiliarisSuccessGene TherapyVisionFutureOutcome MeasureVectorLeadInherited Retinal DegenerationMediatingTranslational StudyClinically RelevantHuman DiseaseBaseStructureLeber&AposPrevent
Grant awards (39)
Models for Therapy of Hereditary Retinal Degeneration$826,381
R01 · FY2025 · EY · contact PI
Retinal-adhesive thermoresponsive gel for AAV-mediated gene delivery to the outer retina$614,243
R01 · FY2025 · EY
Models for Therapy of Hereditary Retinal Degeneration$752,996
R01 · FY2024 · EY
Retinal-adhesive thermoresponsive gel for AAV-mediated gene delivery to the outer retina$722,637
R01 · FY2024 · EY
Translational Research for Retinal Degeneration Therapies$714,886
R01 · FY2024 · EY · contact PI
Instrumentation Module$204,936
P30 · FY2024 · EY · contact PI
Models for Therapy of Hereditary Retinal Degeneration$752,996
R01 · FY2023 · EY
Retinal-adhesive thermoresponsive gel for AAV-mediated gene delivery to the outer retina$719,830
R01 · FY2023 · EY
Translational Research for Retinal Degeneration Therapies$711,050
R01 · FY2023 · EY · contact PI
Instrumentation Module$204,936
P30 · FY2023 · EY · contact PI
Retinal disease models for translational photoreceptor replacement$1,374,254
U24 · FY2022 · EY
Retinal-adhesive thermoresponsive gel for AAV-mediated gene delivery to the outer retina$692,836
R01 · FY2022 · EY
Translational Research for Retinal Degeneration Therapies$689,983
R01 · FY2022 · EY · contact PI
Instrumentation Module$163,925
P30 · FY2022 · EY · contact PI
Retinal disease models for translational photoreceptor replacement$1,373,869
U24 · FY2021 · EY
Translational Research for Retinal Degeneration Therapies$711,340
R01 · FY2021 · EY · contact PI
Instrumentation Module$163,925
P30 · FY2021 · EY · contact PI
Equipment Supplement on NEI U24 EY-029890$150,000
U24 · FY2021 · EY
Retinal disease models for translational photoreceptor replacement$1,373,524
U24 · FY2020 · EY
Translational Research for Retinal Degeneration Therapies$774,244
R01 · FY2020 · EY
Retinal disease models for translational photoreceptor replacement$213,628
U24 · FY2020 · EY
Retinal disease models for translational photoreceptor replacement$1,374,792
U24 · FY2019 · EY
Translational Research for Retinal Degeneration Therapies$774,244
R01 · FY2019 · EY
Retinal disease models for translational photoreceptor replacement$1,401,827
U24 · FY2018 · EY
Translational Research for Retinal Degeneration Therapies$774,244
R01 · FY2018 · EY
Translational Research for Retinal Degeneration Therapies$774,244
R01 · FY2017 · EY
Translational Gene Therapy for Rhodopsin Autosomal Dominant Retinitis Pigmentosa$1,876,891
R24 · FY2016 · EY · contact PI
Translational Research for Retinal Degeneration Therapies$789,494
R01 · FY2016 · EY
Preclinical safety studies$674,641
R24 · FY2016 · EY · contact PI
Large animal therapy studies$616,704
R24 · FY2016 · EY · contact PI
Translational Gene Therapy for Rhodopsin Autosomal Dominant Retinitis Pigmentosa$1,840,747
R24 · FY2015 · EY · contact PI
Large animal therapy studies$706,283
R24 · FY2015 · EY · contact PI
Preclinical safety studies$486,805
R24 · FY2015 · EY · contact PI
Translational Gene Therapy for Rhodopsin Autosomal Dominant Retinitis Pigmentosa$1,342,268
R24 · FY2014 · EY · contact PI
Large animal therapy studies$696,492
R24 · FY2014 · EY · contact PI
Translational Gene Therapy for Rhodopsin Autosomal Dominant Retinitis Pigmentosa$1,336,892
R24 · FY2013 · EY · contact PI
Large animal therapy studies$696,911
R24 · FY2013 · EY · contact PI
Translational Gene Therapy for Rhodopsin Autosomal Dominant Retinitis Pigmentosa$1,492,362
R24 · FY2012 · EY · contact PI
Large animal therapy studies$839,884
R24 · FY2012 · EY · contact PI